19,335 Amphenol Corporation $APH Shares Acquired by Kraematon Investment Advisors Inc.

Kraematon Investment Advisors Inc. grew its holdings in shares of Amphenol Corporation (NYSE:APH) by 97.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 39,128 shares of the electronics maker’s stock after purchasing an additional 19,335 shares during the period. Amphenol makes up about 2.4% of Kraematon Investment Advisors Inc.’s portfolio, making the stock its 12th biggest holding. Kraematon Investment Advisors Inc.’s holdings in Amphenol were worth $3,298,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in APH. Pacific Excel Wealth Advisors Inc. acquired a new stake in shares of Amphenol during the 2nd quarter worth approximately $1,927,000. Evelyn Partners Investment Management Services Ltd lifted its stake in Amphenol by 132.7% in the 1st quarter. Evelyn Partners Investment Management Services Ltd now owns 45,599 shares of the electronics maker’s stock valued at $5,761,000 after buying an additional 26,000 shares in the last quarter. Allen Capital Group LLC boosted its stake in shares of Amphenol by 1,118.7% in the first quarter. Allen Capital Group LLC now owns 39,681 shares of the electronics maker’s stock worth $5,014,000 after acquiring an additional 36,425 shares during the last quarter. Segall Bryant & Hamill LLC acquired a new stake in shares of Amphenol in the first quarter valued at about $5,637,000. Finally, Gabelli Funds LLC raised its holdings in Amphenol by 29.3% in the 1st quarter. Gabelli Funds LLC now owns 193,939 shares of the electronics maker’s stock valued at $24,504,000 after acquiring an additional 43,945 shares during the last quarter. Institutional investors and hedge funds own 97.01% of the company’s stock.

Amphenol Trading Down 9.2%

APH opened at $71.73 on Friday. Amphenol Corporation has a 52 week low of $59.01 and a 52 week high of $89.93. The business has a fifty day simple moving average of $81.42 and a 200-day simple moving average of $75.54. The firm has a market cap of $177.13 billion, a P/E ratio of 31.19, a P/E/G ratio of 0.94 and a beta of 1.27. The company has a quick ratio of 1.42, a current ratio of 1.94 and a debt-to-equity ratio of 0.99.

Amphenol (NYSE:APH) last issued its quarterly earnings data on Wednesday, October 28th. The electronics maker reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.73 by $0.07. The business had revenue of $10.23 billion during the quarter, compared to analysts’ expectations of $9.49 billion. Amphenol had a return on equity of 42.53% and a net margin of 17.95%. The company’s revenue was up 65.1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.93 earnings per share. On average, equities analysts expect that Amphenol Corporation will post 2.84 earnings per share for the current year.

Amphenol Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 13th. Shareholders of record on Tuesday, December 22nd will be given a $0.15 dividend. The ex-dividend date of this dividend is Tuesday, December 22nd. This represents a $0.60 annualized dividend and a yield of 0.8%. This is a decrease from Amphenol’s previous quarterly dividend of $0.25. Amphenol’s dividend payout ratio is presently 21.74%.

Amphenol declared that its Board of Directors has authorized a share repurchase plan on Wednesday, October 28th that allows the company to repurchase $4 billion in outstanding shares. This repurchase authorization allows the electronics maker to purchase up to 2% of its shares through open market purchases. Stock repurchase plans are generally an indication that the company’s board believes its stock is undervalued.

Analyst Upgrades and Downgrades

Several research firms have weighed in on APH. Wolfe Research initiated coverage on shares of Amphenol in a report on Wednesday, September 30th. They issued an “outperform” rating and a $105.00 target price on the stock. Weiss Ratings cut Amphenol from a “buy (a-)” rating to a “buy (b)” rating in a research note on Friday, October 23rd. Wall Street Zen upgraded Amphenol from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. UBS Group upped their price target on Amphenol from $105.00 to $111.00 and gave the company a “buy” rating in a research note on Thursday, October 29th. Finally, Zacks Research upgraded Amphenol from a “hold” rating to a “strong-buy” rating in a report on Friday, October 30th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $108.32.

Insiders Place Their Bets

In other Amphenol news, CEO Richard Norwitt sold 799,576 shares of the business’s stock in a transaction dated Monday, November 2nd. The shares were sold at an average price of $82.48, for a total transaction of $65,949,028.48. Following the sale, the chief executive officer directly owned 3,855,014 shares in the company, valued at $317,961,554.72. This represents a 17.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.42% of the stock is currently owned by corporate insiders.

Amphenol Profile

Amphenol Corporation (NYSE: APH) is a global manufacturer of electrical, electronic and fiber-optic connectors, interconnect systems and related products. Its portfolio includes cable assemblies, sensors, antennas, backplane systems, radio-frequency components and other specialized electronic hardware.

The company serves customers across a range of industries, including automotive, aerospace and defense, information technology and data communications, industrial, mobile networks, commercial aerospace, medical and other markets.